山东大学学报 (医学版) ›› 2023, Vol. 61 ›› Issue (5): 44-50.doi: 10.6040/j.issn.1671-7554.0.2023.0055
• 临床医学 • 上一篇
许月明1,张杰1,姜蕾1,尹力2,赵畔1,许欣1,郝桂敏1
XU Yueming1, ZHANG Jie1, JIANG Lei1, YIN Li2, ZHAO Pan1, XU Xin1, HAO Guimin1
摘要: 目的 探讨人绒毛膜促性腺激素(hCG)日孕酮升高对辅助生殖技术(ART)新鲜周期妊娠结局的影响及与获卵数的关系。 方法 回顾性分析2019年1月至2020年12月于河北医科大学第二医院生殖医学科接受体外受精-胚胎移植(IVF-ET)或卵细胞质内单精子注射(ICSI)新鲜周期移植D3胚胎的不孕患者,共纳入2 437例患者。通过单因素分析、多元Logistic回归分析、平滑曲线拟合及阈值效应分析hCG日孕酮升高对ART新鲜周期妊娠结局的影响,并通过分层分析评估其影响是否与获卵数有关。 结果 所有患者调整混杂因素后,阈值效应分析结果显示,hCG日孕酮≥1.5 ng/mL时,孕酮每增加1 ng/mL,临床妊娠率下降60%(95%CI:0.2~0.7,P=0.004),宫内妊娠率下降70%(95%CI:0.2~0.7,P=0.003),活产率下降70%(95%CI:0.1~0.7,P=0.004)。按获卵数分组后结果显示,获卵数5~10时,hCG日孕酮≥1.8 ng/mL时,孕酮每增加1 ng/mL,临床妊娠率下降100%(95%CI:0.0~0.1,P=0.002);宫内妊娠率下降100%(95%CI:0.0~0.0,P<0.001);hCG日孕酮≥1.6 ng/mL时,孕酮每增加1 ng/mL,活产率下降90%(95%CI:0.0~1.0,P=0.049)。获卵数10~15时,孕酮≥1.1 ng/mL时,孕酮每增加1 ng/mL,临床妊娠率下降70%(95%CI:0.1~0.7,P=0.006),宫内妊娠率下降70%(95%CI:0.1~0.6,P=0.003),活产率下降70%(95%CI:0.1~0.6,P=0.003)。 结论 在接受IVF/ICSI新鲜周期移植的不孕患者中,hCG日孕酮≥1.5 ng/mL是影响临床妊娠率、宫内妊娠率和活产率的独立危险因素。分组后孕酮升高对获卵数5~15的患者影响更为明显,因此,若hCG日孕酮升高且获卵数在5~15之间的患者可行全胚冷冻,以期改善妊娠结局。
中图分类号:
[1] Silverberg KM, Burns WN, Olive DL, et al. Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins [J]. J Clin Endocrinol Metab, 1991, 73(4): 797-803. [2] Edelstein MC, Seltman HJ, Cox BJ, et al. Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome [J]. Fertil Steril, 1990, 54(5): 853-857. [3] Arvis P, Lehert P, Guivarch-Leveque A. Both high and low hcg day progesterone concentrations negatively affect live birth rates in ivf/icsi cycles [J]. Reprod Biomed Online, 2019, 39(5): 852-859. [4] Bosch E, Labarta E, Crespo J, et al. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: Analysis of over 4000 cycles [J]. Hum Reprod, 2010, 25(8): 2092-2100. [5] Venetis CA, Kolibianakis EM, Bosdou JK, et al. Progesterone elevation and probability of pregnancy after ivf: A systematic review and meta-analysis of over 60 000 cycles [J]. Hum Reprod Update, 2013, 19(5): 433-457. [6] Saleh HA, Omran MS, Draz M. Does subtle progesterone rise on the day of hcg affect pregnancy rate in long agonist icsi cycles? [J]. J Assist Reprod Genet, 2009, 26(5): 239-242. [7] Racca A, Santos-Ribeiro S, De Munck N, et al. Impact of late-follicular phase elevated serum progesterone on cumulative live birth rates: Is there a deleterious effect on embryo quality? [J]. Hum Reprod, 2018, 33(5): 860-868. [8] Simon C, Moreau J, Gatimel N, et al. Impact of estradiol and progesterone levels during the late follicular stage on the outcome of gnrh antagonist protocols [J]. Gynecol Endocrinol, 2019, 35(6): 481-484. [9] Hernandez-Nieto C, Lee JA, Alkon-Meadows T, et al. Late follicular phase progesterone elevation during ovarian stimulation is not associated with decreased implantation of chromosomally screened embryos in thaw cycles [J]. Hum Reprod, 2020, 35(8): 1889-1899. [10] Pardinas ML, Nohales M, Labarta E, et al. Elevated serum progesterone does not impact euploidy rates in PGT-A patients [J]. J Assist Reprod Genet, 2021, 38(7): 1819-1826. [11] Neves AR, Santos-Ribeiro S, Garcia-Martinez S, et al. The effect of late-follicular phase progesterone elevation on embryo ploidy and cumulative live birth rates [J]. Reprod Biomed Online, 2021, 43(6): 1063-1069. [12] Kalakota NR, George LC, Morelli SS, et al. Towards an improved understanding of the effects of elevated progesterone levels on human endometrial receptivity and oocyte/embryo quality during assisted reproductive technologies [J]. Cells, 2022, 11(9): 1405. [13] Shufaro Y, Sapir O, Oron G, et al. Progesterone-to-follicle index is better correlated with in vitro fertilization cycle outcome than blood progesterone level [J]. Fertil Steril, 2015, 103(3): 669-674.e663. [14] Venetis CA, Tarlatzis BC. Trying to define the optimal progesterone elevation cut-off in fresh in vitro fertilization cycles: time to evolve our way of thinking [J]. Fertil Steril, 2018, 110(4): 634-635. [15] Lawrenz B, Long J, Stoop D, et al. Impact of stimulation duration and gonadotropin type on the incidence of premature progesterone elevation-a retrospective analysis of the ensure data [J]. Gynecol Endocrinol, 2018, 34(12): 1044-1047. [16] Huang CC, Lien YR, Chen HF, et al. The duration of pre-ovulatory serum progesterone elevation before hcg administration affects the outcome of ivf/icsi cycles [J]. Hum Reprod, 2012, 27(7): 2036-2045. [17] 黎淑贞, 陈希曦, 廖勇彬, 等. 控制性促排卵晚卵泡期孕酮升高天数对临床结局的影响[J]. 生殖医学杂志, 2019, 28(7): 786-790. LI Shuzhen, CHEN Xixi, LIAO Yongbin, et al. Influence of progesterone elevated days in late follicular phase of controlled ovulation induction cycle on clinical outcomes [J]. Journal of Reproductive Medicine, 2019, 28(7): 786-790. [18] 李真, 刘艳丽, 耿爱华, 等. 不同卵泡数孕酮升高持续时间对ivf/icsi妊娠结局的影响[J]. 中国妇幼保健, 2016, 31(16): 3330-3333. [19] Lawrenz B, Beligotti F, Engelmann N, et al. Impact of gonadotropin type on progesterone elevation during ovarian stimulation in gnrh antagonist cycles [J]. Hum Reprod, 2016, 31(11): 2554-2560. [20] Maheshwari A, Pandey S, Shetty A, et al. Obstetric and perinatal outcomes in singleton pregnancies resulting from the transfer of frozen thawed versus fresh embryos generated through in vitro fertilization treatment: a systematic review and meta-analysis[J]. Fertil Steril, 2012, 98(2): 368-377. [21] Shapiro BS, Daneshmand ST, Garner FC, et al. Clinical rationale for cryopreservation of entire embryo cohorts in lieu of fresh transfer [J]. Fertil Steril, 2014, 102(1): 3-9. [22] Fatemi HM, Garcia-Velasco J. Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin-releasing hormone agonist trigger [J]. Fertil Steril, 2015, 103(4): 870-873. [23] Tokgoz VY, Tekin AB. Serum progesterone level above 0.85 ng/mL and progesterone/estradiol ratio may be useful predictors for replacing cleavage-stage with blastocyst-stage embryo transfer in fresh IVF/ICSI cycles without premature progesterone elevation [J]. Arch Gynecol Obstet, 2022, 305(4): 1011-1019. [24] 霍建玮, 刘芸. 促排卵过程中孕酮升高原因及对IVF/ICSI结局影响的研究进展[J]. 生殖医学杂志, 2021, 30(6): 820-826. HUO Jianwei, LIU Yun. Research progress on causes of elevated progesterone during ovulation induction and its influence on IVF/ICSI outcome [J]. Journal of Reproductive Medicine, 2021, 30(6): 820-826. [25] Patton PE, Lim JY, Hickok LR, et al. Precision of progesterone measurements with the use of automated immunoassay analyzers and the impact on clinical decisions for in vitro fertilization [J]. Fertil Steril, 2014, 101(6): 1629-1636. |
[1] | 颜磊,陈子江. 子宫腺肌病合并不孕的治疗[J]. 山东大学学报 (医学版), 2022, 60(7): 43-47. |
[2] | 吴日超,刘红,王泽,高姗姗,李秀芳,石玉华. 40岁及以上女性行体外受精-胚胎移植助孕的妊娠结局分析[J]. 山东大学学报 (医学版), 2022, 60(6): 35-39. |
[3] | 韩晓婷,高文丽,王婷,赵君利. 扳机日及其后添加重组人促黄体激素对黄体期长方案助孕结局的影响[J]. 山东大学学报 (医学版), 2022, 60(12): 31-38. |
[4] | 邓晓惠,郭玲. 免疫治疗在胚胎反复种植失败中的应用进展[J]. 山东大学学报 (医学版), 2021, 59(8): 32-37. |
[5] | 陈伟,郭情情,徐金,方园,孙梅,盛燕. 自然周期联合黄体期卵巢刺激助孕和双重刺激助孕效果的对比分析[J]. 山东大学学报 (医学版), 2021, 59(8): 61-66. |
[6] | 邬晓琳,李萍. 激动剂长方案下促性腺激素使用时长对体外受精胚胎移植妊娠结局的影响[J]. 山东大学学报 (医学版), 2021, 59(7): 32-37. |
[7] | 张秀清,张敬,蒋琪,李晨,刘畅,李瑞静,冯惠娟,耿玲. 腔内理疗对89例薄型子宫内膜冻融胚胎移植患者妊娠结局的影响[J]. 山东大学学报 (医学版), 2020, 58(5): 62-68. |
[8] | 宋海霞,袁彩霞,范玲玲. 体质量指数对夫精人工授精妊娠结局的影响[J]. 山东大学学报 (医学版), 2020, 58(1): 49-53. |
[9] | 冯振花,李元美,崔文娟,司蕊,盛燕,赵涵. 79例低促性腺激素性腺功能减退患者体外受精-胚胎移植结局分析[J]. 山东大学学报 (医学版), 2020, 58(1): 43-48. |
[10] | 张迎春. 人类辅助生殖技术子代安全性问题[J]. 山东大学学报 (医学版), 2019, 57(10): 52-59. |
[11] | 于娜,郭情情,孙梅,盛燕,马增香,秦莹莹. 甲状腺癌术后行IVF/ICSI-ET助孕临床结局[J]. 山东大学学报 (医学版), 2018, 56(9): 54-58. |
[12] | 周慧梅,杨佳欣,曹冬焱,沈铿,向阳,吴鸣,潘凌亚,黄惠芳,郎景和. 早期宫颈癌保留生育功能手术的治疗效果及妊娠结局[J]. 山东大学学报 (医学版), 2018, 56(5): 18-22. |
[13] | 陈士岭,周星宇. 早发性卵巢功能不全的临床诊治进展[J]. 山东大学学报 (医学版), 2018, 56(4): 1-7. |
[14] | 石玉华,李敬. 高龄女性助孕措施选择[J]. 山东大学学报(医学版), 2017, 55(1): 22-25. |
[15] | 杨冬梓,麦卓瑶. 高龄多囊卵巢综合征患者的卵巢储备特点及其助孕结局[J]. 山东大学学报(医学版), 2017, 55(1): 26-32. |
|